Nurses' Wishlist of Cancer Advancements They Hope to See for the Next Decade
We asked our audience about what kind of cancer advancements they wish to see in the next 10 years. Here’s what they had to say.
The last decade was filled with amazing cancer advancements, but there is still much more work to be done. Here are some of the highlights of what our readers are hoping to see in the next 10 years.
- “Patients will be treated with targeted therapy cocktails based on their molecular profiles, rather than individual drugs at a one-at-a-time manner.”
- “More personalized medicines, at affordable costs to patients and the systems.”
- “Solid tumors treated with CAR T-cell therapy.”
- “New therapies to stop resistance to TKIs.”
- “More cancers with progression-free disease.”
- “Approval for sipuleucel-T (Provenge) for newly diagnosed patients with prostate cancer.”
- “Price decreases for standard lab testing.”
With these advancements also come new challenges educational opportunities for oncology nurses. New treatment methods will come with different adverse events to monitor, making nurse-patient communication even more important.
Additionally, as the healthcare system gets more complex with a nearly constant flow of new therapies, the role of the oncology nurse will continue to be critical in the evaluation, care, and maintenance treatment of cancer survivors.
Checkout OncNursingNews.com to stay abreast of the most recent practice-changing research in the field of oncology nursing. Subscribe to our emails to never miss a beat on weekly top stories and breaking news FDA approvals.
